We also analyzed the IL-6 levels through the COVID-19 progression phases according to severity: per the CCDC score, there was a sevenfold and threefold decrease in the MI (p = 0.006) and SI groups, respectively, for days 1–9 versus days 10–16. This evidence concerns the gene IL6 and COVID-19.